S2Medical AB (S2M) — Capital Reinvestment Ratio
Latest as of December 2025:
2.99x
S2Medical AB (S2M) has a Capital Reinvestment Ratio of 2.99x as of December 2025, meaning it reinvests 3% of its operating cash flow (Skr676.00K) in capital expenditures (Skr2.02 Million). See S2M free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
2.99x
Capex / Operating Cash Flow
Operating Cash Flow
Skr676.00K
SEK
Capital Expenditures
Skr2.02 Million
SEK
Data as of
Dec 2025
Most recent filing
S2Medical AB Capital Reinvestment Ratio (2024–2025)
This chart tracks S2Medical AB's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for S2Medical AB (2024–2025)
Year-by-year Capital Reinvestment Ratio for S2Medical AB from 2024 to 2025. For live market cap and broader valuation context, see how much is S2Medical AB worth.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.00x | Skr675.00K | Skr675.00K | ▲ +693.5% |
| 2024 | 0.13x | Skr5.03 Million | Skr634.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow